Basic Information
RNALocate ID: RLID:11001713
RNA Symbol: hsa-miR-124-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-124-3p
RNA ID: miRBase:MIMAT0000422
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23663360
Tissue/Cell Line: Plasma
Method: Next-generation RNA sequencing
Description: Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001752 Mitochondrion Cell line (HEK-293) 22984580
RLID:11001714 Microvesicle Cerebrospinal fluid 24797360
RLID-D:11000075 Exosome Blood
RLID-D:11000350 Microvesicle Blood|Fibroblasts|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-124-3p Inflammatory bowel disease MNDR-E-MI-06103
MNDR hsa-miR-124-3p Multiple sclerosis chronic progressive MNDR-E-MI-06104
MNDR hsa-miR-124-3p Oral squamous cell carcinoma MNDR-E-MI-06105
MNDR hsa-miR-124-3p Medulloblastoma MNDR-E-MI-06106
MNDR hsa-miR-124-3p Estrogen-receptor positive breast cancer MNDR-E-MI-06107
MNDR hsa-miR-124-3p Estrogen-receptor negative breast cancer MNDR-E-MI-06108
MNDR hsa-miR-124-3p Progesterone-receptor positive breast cancer MNDR-E-MI-06109
MNDR hsa-miR-124-3p Progesterone-receptor negative breast cancer MNDR-E-MI-06110
MNDR hsa-miR-124-3p Her2-receptor positive breast cancer MNDR-E-MI-06111
MNDR hsa-miR-124-3p Anencephaly MNDR-E-MI-06112
MNDR hsa-miR-124-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-06113
MNDR hsa-miR-124-3p Lupus nephritis MNDR-E-MI-06114
MNDR hsa-miR-124-3p Prostate cancer MNDR-E-MI-06115
MNDR hsa-miR-124-3p Chronic lymphocytic leukemia MNDR-E-MI-06116
MNDR hsa-miR-124-3p Gastric cancer MNDR-E-MI-06117
MNDR hsa-miR-124-3p Alzheimer disease MNDR-E-MI-06118
MNDR hsa-miR-124-3p Bladder cancer MNDR-E-MI-06119
MNDR hsa-miR-124-3p Dysautonomia familial MNDR-E-MI-06120
MNDR hsa-miR-124-3p Seizures MNDR-E-MI-06121
MNDR hsa-miR-124-3p Friedreich ataxia MNDR-E-MI-06122
MNDR hsa-miR-124-3p Huntington disease MNDR-E-MI-06123
MNDR hsa-miR-124-3p Chorea MNDR-E-MI-06124
MNDR hsa-miR-124-3p Cardiovascular disease MNDR-E-MI-06125
MNDR hsa-miR-124-3p Brain cancer MNDR-E-MI-06126
MNDR hsa-miR-124-3p Lung cancer MNDR-E-MI-06127
MNDR hsa-miR-124-3p Fragile x syndrome MNDR-E-MI-06128
MNDR hsa-miR-124-3p Parkinson disease MNDR-E-MI-06129
MNDR hsa-miR-124-3p Major depressive disorder MNDR-E-MI-06130
MNDR hsa-miR-124-3p Depression MNDR-E-MI-06131
MNDR hsa-miR-124-3p Breast cancer MNDR-E-MI-06132
MNDR hsa-miR-124-3p Cancer MNDR-E-MI-06133
MNDR hsa-miR-124-3p Thyroid cancer MNDR-E-MI-06134
MNDR hsa-miR-124-3p Pituitary neoplasms MNDR-E-MI-06135
MNDR hsa-miR-124-3p Pancreatic cancer MNDR-E-MI-06136
MNDR hsa-miR-124-3p Hepatitis C MNDR-E-MI-06137
MNDR hsa-miR-124-3p Melanoma MNDR-E-MI-06138
MNDR hsa-miR-124-3p Nephroblastoma MNDR-E-MI-06139
MNDR hsa-miR-124-3p Colon cancer MNDR-E-MI-06140
MNDR hsa-miR-124-3p Ischemic attack transient MNDR-E-MI-06141
MNDR hsa-miR-124-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-06142
MNDR hsa-miR-124-3p Familial ovarian cancer MNDR-E-MI-06143
MNDR hsa-miR-124-3p Acromegaly MNDR-E-MI-06144
MNDR hsa-miR-124-3p Kidney cancer MNDR-E-MI-06145
MNDR hsa-miR-124-3p Cerebellar disease MNDR-E-MI-06146
MNDR hsa-miR-124-3p Glioblastoma MNDR-E-MI-06147
MNDR hsa-miR-124-3p Astrocytoma MNDR-E-MI-06148
MNDR hsa-miR-124-3p Glioma MNDR-E-MI-06149
MNDR hsa-miR-124-3p Oligodendroglioma MNDR-E-MI-06150
MNDR hsa-miR-124-3p Teratocarcinoma MNDR-E-MI-06151
MNDR hsa-miR-124-3p Central nervous system disease MNDR-E-MI-06152
MNDR hsa-miR-124-3p Amyotrophic lateral sclerosis MNDR-E-MI-06153
MNDR hsa-miR-124-3p Epilepsy temporal lobe MNDR-E-MI-06154
MNDR hsa-miR-124-3p Osteosarcoma MNDR-E-MI-06155
MNDR hsa-miR-124-3p Ewing sarcoma MNDR-E-MI-06156
MNDR hsa-miR-124-3p Pancreatic duct adenocarcinoma MNDR-E-MI-06157
MNDR hsa-miR-124-3p Meningioma MNDR-E-MI-06158
MNDR hsa-miR-124-3p Liver cancer MNDR-E-MI-06159
MNDR hsa-miR-124-3p Pituitary adenoma MNDR-E-MI-06160
MNDR hsa-miR-124-3p Carcinoma lung non-small-cell MNDR-E-MI-06161
MNDR hsa-miR-124-3p Lung adenocarcinoma MNDR-E-MI-06162
MNDR hsa-miR-124-3p Papillary thyroid carcinoma MNDR-E-MI-06163
MNDR hsa-miR-124-3p Cervical cancer MNDR-E-MI-06164
MNDR hsa-miR-124-3p Renal cell carcinoma MNDR-E-MI-06165
MNDR hsa-miR-124-3p Renal clear cell carcinoma MNDR-E-MI-06166
MNDR hsa-miR-124-3p Biliary tract cancer MNDR-E-MI-06167
MNDR hsa-miR-124-3p Neoplasms of the small intestine MNDR-E-MI-06168
MNDR hsa-miR-124-3p Cholangiocarcinoma MNDR-E-MI-06169
MNDR hsa-miR-124-3p Esophageal cancer MNDR-E-MI-06170
MNDR hsa-miR-124-3p Lung small cell carcinoma MNDR-E-MI-06171
MNDR hsa-miR-124-3p Encephalopathy bovine spongiform MNDR-E-MI-06172
MNDR hsa-miR-124-3p Uveal melanoma MNDR-E-MI-06173
MNDR hsa-miR-124-3p Growth hormone-secreting pituitary adenoma MNDR-E-MI-06174
MNDR hsa-miR-124-3p Bladder transitional cell carcinoma MNDR-E-MI-06175
MNDR hsa-miR-124-3p Progressive supranuclear palsy MNDR-E-MI-06176
MNDR hsa-miR-124-3p Hepatocellular carcinoma MNDR-E-MI-06177
MNDR hsa-miR-124-3p Familiar ovarian carcinoma MNDR-E-MI-06178
MNDR hsa-miR-124-3p B-cell lymphoma MNDR-E-MI-06179
MNDR hsa-miR-124-3p Retinoblastoma MNDR-E-MI-06180
MNDR hsa-miR-124-3p Neuroblastoma MNDR-E-MI-06181
MNDR hsa-miR-124-3p Barrett's adenocarcinoma MNDR-E-MI-06182
MNDR hsa-miR-124-3p Hodgkin lymphoma MNDR-E-MI-06183
MNDR hsa-miR-124-3p Tongue cancer MNDR-E-MI-06184
MNDR hsa-miR-124-3p Ritter's disease MNDR-E-MI-06185
MNDR hsa-miR-124-3p Acute myelogenous leukemia MNDR-E-MI-06186
MNDR hsa-miR-124-3p Colorectal cancer MNDR-E-MI-06187
MNDR hsa-miR-124-3p Nasopharyngeal carcinoma MNDR-E-MI-06188
MNDR hsa-miR-124-3p Type 2 diabetes mellitus MNDR-E-MI-06189
MNDR hsa-miR-124-3p Multiple myeloma MNDR-E-MI-06190
MNDR hsa-miR-124-3p Nasopharyngeal carcinoma MNDR-E-MI-06191
MNDR hsa-miR-124-3p Leukemia lymphoblastic acute MNDR-E-MI-06192
MNDR hsa-miR-124-3p Ovarian epithelial cancer MNDR-E-MI-06193
MNDR hsa-miR-124-3p Uterine cervical neoplasms MNDR-E-MI-06194
MNDR hsa-miR-124-3p Ependymoma MNDR-E-MI-06195
MNDR hsa-miR-124-3p Prostatic neoplasms MNDR-E-MI-06196
MNDR hsa-miR-124-3p Gait ataxia MNDR-E-MI-06197
MNDR hsa-miR-124-3p Intracranial hemorrhage hypertensive MNDR-E-MI-06198
MNDR hsa-miR-124-3p Stroke lacunar MNDR-E-MI-06199
MNDR hsa-miR-124-3p Barrett's carcinogenesis MNDR-E-MI-06200
MNDR hsa-miR-124-3p Breast cancer her3+ negative MNDR-E-MI-06201
MNDR hsa-miR-124-3p Cerebellar neurodegeneration MNDR-E-MI-06202
MNDR hsa-miR-124-3p Cholestatic liver injury MNDR-E-MI-06203
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABHD4 Homo sapiens RR00026289
TOP